Department of Cell and Developmental Biology

February 26, 2025

Vanderbilt University School of Medicine fifth in the nation in NIH research funding

The NIH is the world’s largest public funder of biomedical research. VUSM, which received $586 million in direct and indirect NIH grant support in FY24, has been among the top 10 recipients of NIH funding among U.S. medical schools for nine of the past 15 years.

By Bill Snyder
From left, Nick Negretti, PhD, Bryan Millis, PhD, Jennifer Sucre, MD, and Chris Jetter co-led a research team that achieved a new view of lung development — one that could improve outcomes for premature babies. (photo by Donn Jones)
February 24, 2025

Bottling a mouse ‘superpower’ may heal lungs damaged by premature birth: study

Watch the video to hear Jennifer Sucre, MD, talk about how this study upends what people are taught about how the lung develops.

Using a four-dimensional microscopy technique, researchers at Vanderbilt have created 3D video images of mouse lung tissue grown in the laboratory.

By Bill Snyder
February 6, 2025

Waddell Walker Hancock Cancer Discovery Fund names two more scholars 

The funds will support Justin Balko’s research on breast cancer and Kathleen DelGiorno’s research on pancreatic cancer.

By Tom Wilemon
November 26, 2024

What’s all the tuft about?

Vanderbilt researchers used advanced imaging techniques to detail the microscopic structure of intestinal tuft cells, highlighting their unique organization of the structural protein actin.

By Amanda Ruelas
November 21, 2024

Ken Lau and Eunyoung Choi named 2024 Stanley Cohen Innovation Fund awardees

By Marissa Shapiro
October 2, 2024

Grant funds quest to expand immunotherapy efficacy for colorectal cancer  

The study seeks to understand the mechanisms of colorectal cancer and builds on recent Vanderbilt research.

By Tom Wilemon
August 29, 2024

Study finds human milk component may protect adult intestinal health

The research may lead to new treatments for diseases such as inflammatory bowel disease and mucositis, a severe complication of chemotherapy.
By Bill Snyder
June 11, 2024

2024 Chancellor Faculty Fellows selected

Each fellow holds the title for two years, receives $40,000 per year to support their work, and meets with their cohort to exchange ideas, build a broader intellectual community and engage in academic leadership development.
By Kathy Whitney
June 4, 2024

Grant funds research for therapies to prevent stomach cancer

The funds will help launch a clinical trial in the U.S. with one of the therapies and compare it with another therapy from an ongoing clinical trial in Japan.
By Tom Wilemon
December 11, 2023

Colorectal cancer ‘cartography’ reveals an avenue to improved immunotherapy

Vanderbilt University Medical Center researchers have discovered why most colorectal tumors escape detection and destruction by the body’s immune system.
By Bill Snyder
November 15, 2023

Novel C. diff structures are required for infection, offer new therapeutic targets

Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs.
By Leigh MacMillan
July 5, 2023

Vanderbilt researchers envision the potential to grow new lungs

Using a four-dimensional microscope that allows them to watch a tissue putting itself together, researchers at Vanderbilt University Medical Center have achieved a rare feat in science — they have shattered a long-standing dogma about how the lung develops.
By Bill Snyder
July 3, 2023

Vanderbilt investigators land Keck Foundation grant for groundbreaking genetic research

Vanderbilt scientists have received a $1.2 million award from the W. M. Keck Foundation for their groundbreaking project, “Genetic Intolerance Patterns as a Treasure Map to Genes that Define Us as Human.”
By VUMC News and Communications
1 2 3 … 13